A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
for mCRPC (Metastatic Castration-resistant Prostate Cancer)
18 locations incl. Fountain Valley
Sponsor: Pathos AI, Inc.
Sex: Male·Age: 18+
Code: NCT06785636·Phase 1, Phase 2·Recruiting